Tenax Therapeutics (TENX) Inventory Average (2011 - 2013)
Tenax Therapeutics recorded quarterly Inventory Average of $103571.0 in Q2 2013, down 4.67% quarter-over-quarter from $108647.5 in Q1 2013, and up 3.53% year-over-year from $100038.5 in Q2 2012.
Tenax Therapeutics' Inventory Average history runs 3 years deep, the most recent figure standing at $103571.0 for Q2 2013.
- In Q2 2013, Inventory Average rose 3.53% year-over-year to $103571.0; the TTM figure through Apr 2013 stood at $103571.0 (up 3.53% YoY), while the FY2013 annual figure was $91287.0, down 46.42% from the prior year.
- Inventory Average came in at $103571.0 for Q2 2013 at Tenax Therapeutics, down from $108647.5 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $231434.0 in Q3 2011 to a low of $98753.5 in Q3 2012.
- A 3-year average of $126376.0 and a median of $107430.5 in 2012 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average slumped 57.33% in 2012 and advanced 3.53% in 2013, its largest moves.
- Tenax Therapeutics' Inventory Average stood at $150603.0 in 2011, then decreased by 25.8% to $111747.0 in 2012, then slipped by 7.32% to $103571.0 in 2013.
- According to Business Quant data, Inventory Average over the past three periods registered $103571.0, $108647.5, and $111747.0 for Q2 2013, Q1 2013, and Q4 2012 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 103,571.00 |
| Jan 31, 2013 | 108,647.50 |
| Oct 31, 2012 | 111,747.00 |
| Jul 31, 2012 | 98,753.50 |
| Apr 30, 2012 | 100,038.50 |
| Jan 31, 2012 | 106,213.50 |
| Oct 31, 2011 | 150,603.00 |
| Jul 31, 2011 | 231,434.00 |